Quick Heal Technologies Ltd: Share Price Analysis, Intrinsic Value & Fundamentals (2025)

Share Price and Basic Stock Data

Last Updated: March 8, 2025, 11:02 am

Market Cap	1,691 Cr.
Current Price	313
High / Low	826/272
Stock P/E	75.7
Book Value	81.0
Dividend Yield	0.96 %
ROCE	5.69 %
ROE	5.30 %
Face Value	10.0
PEG Ratio	-3.12

Stock P/E, Current Price, and Intrinsic Value Over Time

Stock P/E Current Price Intrinsic Value

View Share Price Target for Quick Heal Technologies Ltd

Competitors of Quick Heal Technologies Ltd

Stock Name ⇩	Market Cap ⇩	Current Price ⇩	High / Low ⇩	Stock P/E ⇩	Book Value ⇩	Dividend Yield ⇩	ROCE ⇩	ROE ⇩	Face Value ⇩
Visesh Infotecnics Ltd	125 Cr.	0.33	0.57/0.33		1.14	0.00 %	0.88 %	0.82 %	1.00
Mudunuru Ltd	22.6 Cr.	7.23	15.6/5.41		0.34	0.00 %	72.9 %	374 %	2.00
Naapbooks Ltd	94.7 Cr.	105	159/54.0	40.6	20.0	0.00 %	17.4 %	13.6 %	10.0
IB Infotech Enterprises Ltd	21.1 Cr.	165	245/113	27.1	16.8	0.61 %	69.9 %	50.5 %	10.0
Hit Kit Global Solutions Ltd	7.19 Cr.	1.55	1.55/0.91	20.0	2.08	0.00 %	1.92 %	1.94 %	2.00
Industry Average	19,195.34 Cr	566.73		79.98	121.67	0.84%	21.53%	64.55%	6.83

All Competitor Stocks of Quick Heal Technologies Ltd

Quarterly Result

Metric	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024
Sales	79.62	103.71	61.08	100.94	66.80	49.28	51.44	78.36	81.92	80.03	70.29	73.49	70.61
Expenses	59.15	68.84	60.03	72.56	78.17	65.45	66.52	67.39	70.30	69.99	67.70	70.42	74.38
Operating Profit	20.47	34.87	1.05	28.38	-11.37	-16.17	-15.08	10.97	11.62	10.04	2.59	3.07	-3.77
OPM %	25.71%	33.62%	1.72%	28.12%	-17.02%	-32.81%	-29.32%	14.00%	14.18%	12.55%	3.68%	4.18%	-5.34%
Other Income	3.63	5.67	3.20	5.40	3.47	10.06	4.73	5.69	4.15	6.82	5.06	5.20	4.91
Interest	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.13	0.05	0.05	0.06
Depreciation	4.54	4.58	3.95	4.14	4.17	3.73	2.93	3.25	3.24	3.18	2.79	3.15	3.39
Profit before tax	19.56	35.96	0.30	29.64	-12.07	-9.84	-13.28	13.41	12.53	13.55	4.81	5.07	-2.31
Tax %	26.99%	21.89%	40.00%	25.24%	-23.03%	-32.52%	-3.92%	3.80%	19.71%	-3.62%	16.22%	18.15%	-104.76%
Net Profit	14.28	28.09	0.18	22.16	-9.29	-6.64	-12.76	12.90	10.06	14.04	4.03	4.15	0.11
EPS in Rs	2.46	4.84	0.03	3.82	-1.75	-1.25	-2.40	2.43	1.89	2.62	0.75	0.77	0.02

Last Updated: February 28, 2025, 5:37 pm

Below is a detailed analysis of the quarterly data for Quick Heal Technologies Ltd based on the most recent figures (Dec 2024) and their trends compared to the previous period:

For Sales, as of Dec 2024, the value is ₹70.61 Cr.. The value appears to be declining and may need further review. It has decreased from 73.49 Cr. (Sep 2024) to ₹70.61 Cr., marking a decrease of 2.88 Cr..
For Expenses, as of Dec 2024, the value is ₹74.38 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 70.42 Cr. (Sep 2024) to ₹74.38 Cr., marking an increase of ₹3.96 Cr..
For Operating Profit, as of Dec 2024, the value is ₹-3.77 Cr.. The value appears to be declining and may need further review. It has decreased from 3.07 Cr. (Sep 2024) to ₹-3.77 Cr., marking a decrease of 6.84 Cr..
For OPM %, as of Dec 2024, the value is -5.34%. The value appears to be declining and may need further review. It has decreased from 4.18% (Sep 2024) to -5.34%, marking a decrease of 9.52%.
For Other Income, as of Dec 2024, the value is ₹4.91 Cr.. The value appears to be declining and may need further review. It has decreased from 5.20 Cr. (Sep 2024) to ₹4.91 Cr., marking a decrease of 0.29 Cr..
For Interest, as of Dec 2024, the value is ₹0.06 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 0.05 Cr. (Sep 2024) to ₹0.06 Cr., marking an increase of ₹0.01 Cr..
For Depreciation, as of Dec 2024, the value is ₹3.39 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3.15 Cr. (Sep 2024) to ₹3.39 Cr., marking an increase of ₹0.24 Cr..
For Profit before tax, as of Dec 2024, the value is ₹-2.31 Cr.. The value appears to be declining and may need further review. It has decreased from 5.07 Cr. (Sep 2024) to ₹-2.31 Cr., marking a decrease of 7.38 Cr..
For Tax %, as of Dec 2024, the value is -104.76%. The value appears to be improving (decreasing) as expected. It has decreased from 18.15% (Sep 2024) to -104.76%, marking a decrease of 122.91%.
For Net Profit, as of Dec 2024, the value is ₹0.11 Cr.. The value appears to be declining and may need further review. It has decreased from 4.15 Cr. (Sep 2024) to ₹0.11 Cr., marking a decrease of 4.04 Cr..
For EPS in Rs, as of Dec 2024, the value is 0.02. The value appears to be declining and may need further review. It has decreased from ₹0.77 (Sep 2024) to 0.02, marking a decrease of ₹0.75.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: March 6, 2025, 3:06 pm

Metric	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	TTM
Sales	205	243	286	302	300	318	315	286	333	342	278	292	294
Expenses	101	157	194	200	210	198	187	195	192	235	276	274	282
Operating Profit	104	85	92	102	90	120	128	92	141	107	2	18	12
OPM %	51%	35%	32%	34%	30%	38%	41%	32%	42%	31%	1%	6%	4%
Other Income	11	11	8	10	25	30	33	31	24	19	22	21	22
Interest	0	0	0	0	0	0	0	0	0	0	0	0	0
Depreciation	4	11	20	24	31	27	24	22	19	17	16	13	13
Profit before tax	110	86	80	88	84	123	137	101	146	109	8	26	21
Tax %	30%	32%	33%	34%	37%	33%	33%	27%	27%	23%	20%	8%
Net Profit	77	58	54	58	53	83	92	74	107	83	6	24	22
EPS in Rs	100.74	9.56	8.81	8.27	7.59	11.79	13.01	11.59	16.66	14.34	1.21	4.53	4.16
Dividend Payout %	2%	78%	85%	30%	33%	25%	15%	35%	24%	31%	207%	66%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year	2013-2014	2014-2015	2015-2016	2016-2017	2017-2018	2018-2019	2019-2020	2020-2021	2021-2022	2022-2023	2023-2024
YoY Net Profit Growth (%)	-24.68%	-6.90%	7.41%	-8.62%	56.60%	10.84%	-19.57%	44.59%	-22.43%	-92.77%	300.00%
Change in YoY Net Profit Growth (%)	0.00%	17.78%	14.30%	-16.03%	65.22%	-45.76%	-30.41%	64.16%	-67.02%	-70.34%	392.77%

Quick Heal Technologies Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2013-2014 to 2023-2024.

Growth

Compounded Sales Growth
10 Years:	2%
5 Years:	-2%
3 Years:	-4%
TTM:	13%

Compounded Profit Growth
10 Years:	-9%
5 Years:	-24%
3 Years:	-40%
TTM:	527%

Stock Price CAGR
10 Years:	%
5 Years:	28%
3 Years:	17%
1 Year:	-49%

Return on Equity
10 Years:	10%
5 Years:	9%
3 Years:	6%
Last Year:	5%

Last Updated: Unknown

Balance Sheet

Last Updated: February 12, 2025, 3:00 pm

Month	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Sep 2024
Equity Capital	8	61	61	70	70	70	71	64	64	58	53	54	54
Reserves	277	271	270	559	592	653	719	580	687	570	367	383	383
Borrowings	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Liabilities	29	47	97	88	72	57	63	52	75	88	74	76	80
Total Liabilities	314	380	428	717	734	781	853	697	827	716	493	513	517
Fixed Assets	38	82	111	142	185	173	165	158	146	137	124	117	119
CWIP	29	55	74	55	14	14	11	3	2	0	0	3	1
Investments	139	131	130	115	182	306	390	310	416	318	198	190	181
Other Assets	107	111	113	405	353	287	288	225	263	261	171	203	216
Total Assets	314	380	428	717	734	781	853	697	827	716	493	513	517

Below is a detailed analysis of the balance sheet data for Quick Heal Technologies Ltd based on the most recent figures (Sep 2024) and their trends compared to the previous period:

For Equity Capital, as of Sep 2024, the value is ₹54.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded ₹54.00 Cr..
For Reserves, as of Sep 2024, the value is ₹383.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded ₹383.00 Cr..
For Borrowings, as of Sep 2024, the value is ₹0.00 Cr.. The value remains steady. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. There is no change compared to the previous period (Mar 2024) which recorded ₹0.00 Cr..
For Other Liabilities, as of Sep 2024, the value is ₹80.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from ₹76.00 Cr. (Mar 2024) to ₹80.00 Cr., marking an increase of 4.00 Cr..
For Total Liabilities, as of Sep 2024, the value is ₹517.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from ₹513.00 Cr. (Mar 2024) to ₹517.00 Cr., marking an increase of 4.00 Cr..
For Fixed Assets, as of Sep 2024, the value is ₹119.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹117.00 Cr. (Mar 2024) to ₹119.00 Cr., marking an increase of 2.00 Cr..
For CWIP, as of Sep 2024, the value is ₹1.00 Cr.. The value appears to be declining and may need further review. It has decreased from ₹3.00 Cr. (Mar 2024) to ₹1.00 Cr., marking a decrease of 2.00 Cr..
For Investments, as of Sep 2024, the value is ₹181.00 Cr.. The value appears to be declining and may need further review. It has decreased from ₹190.00 Cr. (Mar 2024) to ₹181.00 Cr., marking a decrease of 9.00 Cr..
For Other Assets, as of Sep 2024, the value is ₹216.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹203.00 Cr. (Mar 2024) to ₹216.00 Cr., marking an increase of 13.00 Cr..
For Total Assets, as of Sep 2024, the value is ₹517.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹513.00 Cr. (Mar 2024) to ₹517.00 Cr., marking an increase of 4.00 Cr..

Notably, the Reserves (₹383.00 Cr.) exceed the Borrowings (0.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Reserves and Borrowings Chart

Cash Flow

Month	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Cash from Operating Activity +	68	61	77	78	36	94	61	71	99	80	31	18
Cash from Investing Activity +	-63	-59	-53	-163	-73	-122	-37	148	-92	126	185	6
Cash from Financing Activity +	-1	-2	-18	189	-20	-19	-24	-221	0	-214	-212	2
Net Cash Flow	4	-1	7	104	-57	-47	1	-3	6	-9	4	26

Free Cash Flow

Month	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Free Cash Flow	104.00	85.00	92.00	102.00	90.00	120.00	128.00	92.00	141.00	107.00	2.00	18.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

Month	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Debtor Days	138	104	83	112	118	118	145	144	165	184	161	165
Inventory Days			181	144
Days Payable			864	1,103
Cash Conversion Cycle	138	104	-600	-847	118	118	145	144	165	184	161	165
Working Capital Days	103	52	-23	29	49	70	92	94	98	102	83	88
ROCE %	44%	27%	24%	18%	14%	18%	18%	14%	21%	15%	0%	6%

Financial Efficiency Indicators Chart

Share Holding Pattern

Month	Sep 2021	Dec 2021	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024
Promoters	72.99%	72.92%	72.86%	72.84%	72.78%	73.08%	73.08%	73.08%	73.06%	72.76%	72.48%	72.44%
FIIs	0.97%	1.57%	1.77%	1.74%	1.76%	2.17%	2.04%	2.02%	1.56%	1.66%	1.65%	1.54%
DIIs	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	1.13%	1.44%	2.06%	2.41%
Public	26.04%	25.51%	25.37%	25.42%	25.45%	24.76%	24.89%	24.91%	24.23%	24.13%	23.81%	23.61%
No. of Shareholders	69,621	66,992	67,491	66,769	75,044	66,028	65,119	63,445	57,528	50,249	46,923	46,799

Shareholding Pattern Chart

No. of Shareholders

This stock is not held by any mutual fund

ROCE Trend

EPS Trend

Key Financial Ratios

Month	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20
FaceValue	10.00	10.00	10.00	10.00	10.00
Basic EPS (Rs.)	4.56	1.14	14.01	16.66	11.34
Diluted EPS (Rs.)	4.48	1.14	13.94	16.65	11.34
Cash EPS (Rs.)	6.88	4.22	17.34	19.70	14.97
Book Value[Excl.RevalReserv]/Share (Rs.)	81.67	79.09	108.19	117.04	100.32
Book Value[Incl.RevalReserv]/Share (Rs.)	81.67	79.09	108.19	117.04	100.32
Revenue From Operations / Share (Rs.)	54.52	52.40	58.94	51.87	44.57
PBDIT / Share (Rs.)	7.28	4.52	21.73	25.80	19.16
PBIT / Share (Rs.)	4.92	1.51	18.73	22.76	15.78
PBT / Share (Rs.)	4.90	1.51	18.73	22.76	15.78
Net Profit / Share (Rs.)	4.53	1.21	14.34	16.66	11.59
NP After MI And SOA / Share (Rs.)	4.53	1.21	14.34	16.66	11.59
PBDIT Margin (%)	13.34	8.63	36.87	49.73	42.98
PBIT Margin (%)	9.02	2.88	31.78	43.87	35.40
PBT Margin (%)	8.98	2.88	31.78	43.87	35.40
Net Profit Margin (%)	8.30	2.30	24.33	32.12	26.00
NP After MI And SOA Margin (%)	8.30	2.30	24.33	32.12	26.00
Return on Networth / Equity (%)	5.54	1.52	13.25	14.23	11.55
Return on Capital Employeed (%)	5.99	1.90	17.25	19.41	15.67
Return On Assets (%)	4.72	1.29	11.62	12.94	10.68
Asset Turnover Ratio (%)	0.58	0.46	0.44	0.43	0.36
Current Ratio (X)	4.96	4.50	6.20	8.53	9.56
Quick Ratio (X)	4.93	4.43	6.15	8.49	9.43
Inventory Turnover Ratio (X)	0.11	0.23	0.24	0.21	0.14
Dividend Payout Ratio (NP) (%)	54.74	407.96	27.85	0.00	51.76
Dividend Payout Ratio (CP) (%)	36.02	116.61	23.03	0.00	40.08
Earning Retention Ratio (%)	45.26	-307.96	72.15	0.00	48.24
Cash Earning Retention Ratio (%)	63.98	-16.61	76.97	0.00	59.92
Interest Coverage Ratio (X)	299.54	0.00	0.00	0.00	0.00
Interest Coverage Ratio (Post Tax) (X)	187.46	0.00	0.00	0.00	0.00
Enterprise Value (Cr.)	2480.96	695.04	966.92	1113.79	441.62
EV / Net Operating Revenue (X)	8.50	2.50	2.83	3.34	1.54
EV / EBITDA (X)	63.71	28.95	7.67	6.72	3.59
MarketCap / Net Operating Revenue (X)	8.63	2.54	3.01	3.60	1.82
Retention Ratios (%)	45.25	-307.96	72.14	0.00	48.23
Price / BV (X)	5.76	1.68	1.64	1.59	0.80
Price / Net Operating Revenue (X)	8.63	2.54	3.01	3.60	1.82
EarningsYield	0.01	0.01	0.08	0.08	0.14

After reviewing the key financial ratios for Quick Heal Technologies Ltd, here is a detailed analysis based on the latest available data and recent trends:

For FaceValue, as of Mar 24, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 10.00.
For Basic EPS (Rs.), as of Mar 24, the value is 4.56. This value is below the healthy minimum of 5. It has increased from 1.14 (Mar 23) to 4.56, marking an increase of 3.42.
For Diluted EPS (Rs.), as of Mar 24, the value is 4.48. This value is below the healthy minimum of 5. It has increased from 1.14 (Mar 23) to 4.48, marking an increase of 3.34.
For Cash EPS (Rs.), as of Mar 24, the value is 6.88. This value is within the healthy range. It has increased from 4.22 (Mar 23) to 6.88, marking an increase of 2.66.
For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 81.67. It has increased from 79.09 (Mar 23) to 81.67, marking an increase of 2.58.
For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 81.67. It has increased from 79.09 (Mar 23) to 81.67, marking an increase of 2.58.
For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 54.52. It has increased from 52.40 (Mar 23) to 54.52, marking an increase of 2.12.
For PBDIT / Share (Rs.), as of Mar 24, the value is 7.28. This value is within the healthy range. It has increased from 4.52 (Mar 23) to 7.28, marking an increase of 2.76.
For PBIT / Share (Rs.), as of Mar 24, the value is 4.92. This value is within the healthy range. It has increased from 1.51 (Mar 23) to 4.92, marking an increase of 3.41.
For PBT / Share (Rs.), as of Mar 24, the value is 4.90. This value is within the healthy range. It has increased from 1.51 (Mar 23) to 4.90, marking an increase of 3.39.
For Net Profit / Share (Rs.), as of Mar 24, the value is 4.53. This value is within the healthy range. It has increased from 1.21 (Mar 23) to 4.53, marking an increase of 3.32.
For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 4.53. This value is within the healthy range. It has increased from 1.21 (Mar 23) to 4.53, marking an increase of 3.32.
For PBDIT Margin (%), as of Mar 24, the value is 13.34. This value is within the healthy range. It has increased from 8.63 (Mar 23) to 13.34, marking an increase of 4.71.
For PBIT Margin (%), as of Mar 24, the value is 9.02. This value is below the healthy minimum of 10. It has increased from 2.88 (Mar 23) to 9.02, marking an increase of 6.14.
For PBT Margin (%), as of Mar 24, the value is 8.98. This value is below the healthy minimum of 10. It has increased from 2.88 (Mar 23) to 8.98, marking an increase of 6.10.
For Net Profit Margin (%), as of Mar 24, the value is 8.30. This value is within the healthy range. It has increased from 2.30 (Mar 23) to 8.30, marking an increase of 6.00.
For NP After MI And SOA Margin (%), as of Mar 24, the value is 8.30. This value is within the healthy range. It has increased from 2.30 (Mar 23) to 8.30, marking an increase of 6.00.
For Return on Networth / Equity (%), as of Mar 24, the value is 5.54. This value is below the healthy minimum of 15. It has increased from 1.52 (Mar 23) to 5.54, marking an increase of 4.02.
For Return on Capital Employeed (%), as of Mar 24, the value is 5.99. This value is below the healthy minimum of 10. It has increased from 1.90 (Mar 23) to 5.99, marking an increase of 4.09.
For Return On Assets (%), as of Mar 24, the value is 4.72. This value is below the healthy minimum of 5. It has increased from 1.29 (Mar 23) to 4.72, marking an increase of 3.43.
For Asset Turnover Ratio (%), as of Mar 24, the value is 0.58. It has increased from 0.46 (Mar 23) to 0.58, marking an increase of 0.12.
For Current Ratio (X), as of Mar 24, the value is 4.96. This value exceeds the healthy maximum of 3. It has increased from 4.50 (Mar 23) to 4.96, marking an increase of 0.46.
For Quick Ratio (X), as of Mar 24, the value is 4.93. This value exceeds the healthy maximum of 2. It has increased from 4.43 (Mar 23) to 4.93, marking an increase of 0.50.
For Inventory Turnover Ratio (X), as of Mar 24, the value is 0.11. This value is below the healthy minimum of 4. It has decreased from 0.23 (Mar 23) to 0.11, marking a decrease of 0.12.
For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 54.74. This value exceeds the healthy maximum of 50. It has decreased from 407.96 (Mar 23) to 54.74, marking a decrease of 353.22.
For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 36.02. This value is within the healthy range. It has decreased from 116.61 (Mar 23) to 36.02, marking a decrease of 80.59.
For Earning Retention Ratio (%), as of Mar 24, the value is 45.26. This value is within the healthy range. It has increased from -307.96 (Mar 23) to 45.26, marking an increase of 353.22.
For Cash Earning Retention Ratio (%), as of Mar 24, the value is 63.98. This value is within the healthy range. It has increased from -16.61 (Mar 23) to 63.98, marking an increase of 80.59.
For Interest Coverage Ratio (X), as of Mar 24, the value is 299.54. This value is within the healthy range. It has increased from 0.00 (Mar 23) to 299.54, marking an increase of 299.54.
For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 187.46. This value is within the healthy range. It has increased from 0.00 (Mar 23) to 187.46, marking an increase of 187.46.
For Enterprise Value (Cr.), as of Mar 24, the value is 2,480.96. It has increased from 695.04 (Mar 23) to 2,480.96, marking an increase of 1,785.92.
For EV / Net Operating Revenue (X), as of Mar 24, the value is 8.50. This value exceeds the healthy maximum of 3. It has increased from 2.50 (Mar 23) to 8.50, marking an increase of 6.00.
For EV / EBITDA (X), as of Mar 24, the value is 63.71. This value exceeds the healthy maximum of 15. It has increased from 28.95 (Mar 23) to 63.71, marking an increase of 34.76.
For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 8.63. This value exceeds the healthy maximum of 3. It has increased from 2.54 (Mar 23) to 8.63, marking an increase of 6.09.
For Retention Ratios (%), as of Mar 24, the value is 45.25. This value is within the healthy range. It has increased from -307.96 (Mar 23) to 45.25, marking an increase of 353.21.
For Price / BV (X), as of Mar 24, the value is 5.76. This value exceeds the healthy maximum of 3. It has increased from 1.68 (Mar 23) to 5.76, marking an increase of 4.08.
For Price / Net Operating Revenue (X), as of Mar 24, the value is 8.63. This value exceeds the healthy maximum of 3. It has increased from 2.54 (Mar 23) to 8.63, marking an increase of 6.09.
For EarningsYield, as of Mar 24, the value is 0.01. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 23) which recorded 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of Quick Heal Technologies Ltd as of March 12, 2025 is: ₹262.48

Calculation basis:

Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of March 12, 2025, Quick Heal Technologies Ltd is Overvalued by 16.14% compared to the current share price 313.00

Intrinsic Value of Quick Heal Technologies Ltd as of March 12, 2025 is: 198.87

Calculation basis:

Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of March 12, 2025, Quick Heal Technologies Ltd is Overvalued by 36.46% compared to the current share price 313.00

Last 5 Year EPS CAGR: -24.23%

*Investments are subject to market risks

Strength and Weakness

Strength	Weakness
The stock has a high average ROCE of 18.25%, which is a positive sign. The stock has a low average Cash Conversion Cycle of -0.42, which is a positive sign. The company has higher reserves (485.46 cr) compared to borrowings (0.00 cr), indicating strong financial stability. The company has shown consistent growth in sales (291.85 cr) and profit (86.08 cr) over the years.	The stock has a high average Working Capital Days of 69.75, which may not be favorable.

Stock Analysis

Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Quick Heal Technologies Ltd:
1. Net Profit Margin: 8.3%
  - Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
2. ROCE: 5.99% (Industry Average ROCE: 21.53%)
  - ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
3. ROE%: 5.54% (Industry Average ROE: 64.55%)
  - ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
4. Interest Coverage Ratio (Post Tax): 187.46
  - Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
5. Quick Ratio: 4.93
  - Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
6. Stock P/E: 75.7 (Industry average Stock P/E: 79.98)
  - Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
7. Total Debt / Equity: 0
  - Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
Stock Rating:

About the Company - Qualitative Analysis

Quick Heal Technologies Ltd. is a Public Limited Listed company incorporated on 07/08/1995 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L72200MH1995PLC091408 and registration number is 091408. Currently Company is involved in the business activities of Research and experimental development on social sciences and humanities. Company's Total Operating Revenue is Rs. 291.75 Cr. and Equity Capital is Rs. 53.51 Cr. for the Year ended 31/03/2024.

INDUSTRY	ADDRESS	CONTACT
IT Consulting & Software	Solitaire Business Hub, Office No. 7010 C & D, Pune Maharashtra 411014	cs@quickheal.co.in http://www.quickheal.co.in

Management
Name	Position Held
Dr. Kailash Sahebrao Katkar	Chairman & Managing Director
Dr. Sanjay Sahebrao Katkar	Joint Managing Director
Mr. Shailesh Lakhani	Non Executive Director
Mr. Amitabha Mukhopadhyay	Independent Director
Air M'shal (Retd.) Bhushan Nilkanth Gokhale	Independent Director
Ms. Apurva Pradeep Joshi	Independent Director
Mr. Richard Stiennon	Independent Director

FAQ

What is the latest intrinsic value of Quick Heal Technologies Ltd?

The latest intrinsic value of Quick Heal Technologies Ltd as on 11 March 2025 is ₹262.48, which is 16.14% lower than the current market price of 313.00, indicating the stock is overvalued by 16.14%. The intrinsic value of Quick Heal Technologies Ltd is calculated using PE ratio method. The stock has a market capitalization of ₹1,691 Cr. and recorded a high/low of ₹826/272 during the current fiscal year 2024-2025. As of Sep 2024, the company has reserves of ₹383 Cr and total liabilities of ₹517 Cr.

What is the Market Cap of Quick Heal Technologies Ltd?

The Market Cap of Quick Heal Technologies Ltd is 1,691 Cr..

What is the current Stock Price of Quick Heal Technologies Ltd as on 11 March 2025?

The current stock price of Quick Heal Technologies Ltd as on 11 March 2025 is ₹313.

What is the High / Low of Quick Heal Technologies Ltd stocks in FY 2024-2025?

In FY 2024-2025, the High / Low of Quick Heal Technologies Ltd stocks is ₹826/272.

What is the Stock P/E of Quick Heal Technologies Ltd?

The Stock P/E of Quick Heal Technologies Ltd is 75.7.

What is the Book Value of Quick Heal Technologies Ltd?

The Book Value of Quick Heal Technologies Ltd is 81.0.

What is the Dividend Yield of Quick Heal Technologies Ltd?

The Dividend Yield of Quick Heal Technologies Ltd is 0.96 %.

What is the ROCE of Quick Heal Technologies Ltd?

The ROCE of Quick Heal Technologies Ltd is 5.69 %.

What is the ROE of Quick Heal Technologies Ltd?

The ROE of Quick Heal Technologies Ltd is 5.30 %.

What is the Face Value of Quick Heal Technologies Ltd?

The Face Value of Quick Heal Technologies Ltd is 10.0.